European specialist investor Gilde Healthcare has raised €200 million (US$224 million) for its third private equity fund, Gilde Healthcare Services III. The fund will focus on healthcare providers, suppliers of medical products and service providers in the lower mid-market.
The fund was raised with Dutch institutional investors including, among others, PGGM/Pensioenfonds Zorg en Welzijn and Rabo Corporate Investments and various international fund-of-fund investors. To date, Gilde Healthcare has raised more than €1 billion for its dedicated healthcare investment funds.
Recent private equity investments include hospital software provider Performation, integrated telecom solutions provider Zetacom and drug discovery contract research organisation MercachemSyncom.
“We see a strong deal flow of healthcare providers, suppliers of medical products and service providers in the Benelux and DACH regions. Via our local presence we are well-positioned to source proprietary healthcare transactions in the lower midmarket,” said managing partner Jasper van Gorp.
The new private equity fund is focused on established and profitable businesses in Europe with an EBITDA of between €2-15 million, preferably headquartered in the Benelux or Germany, Switzerland and Austria.